Advertisement
Advertisement
GDRX
GoodRx Holdings, Inc. Class A Common Stock
2.92
USDSponsored
+0.08
+2.82%
May 08, 15:59 UTC -4
Closed
After-Market
2.91
-0.01
-0.34%
GDRX Earnings Reports
Positive Surprise Ratio
GDRX beat 12 of 22 last estimates.
55%
Next Report
Date of Next Report
Aug 04, 2026
Estimate for Q2 26 (Revenue/ EPS)
$193.84M
/$0.08
Implied change from Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q2 25 (Revenue/ EPS)
-4.54%
/-11.11%
GoodRx Holdings, Inc. Class A Common Stock earnings per share and revenue
On May 07, 2026, GDRX reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of 0.07 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 188.84 million, with a --% difference. The market reacted with a +10.51% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 12 analysts forecast an EPS of 0.08 USD, with revenue projected to reach 193.84 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Establishment Labs Holdings Inc.
Report Date
May 06, 2026 For Q1 26
Estimate
-$0.35
Actual
-$0.40
Surprise
-12.80%
Progyny, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.30
Actual
$0.50
Surprise
+63.99%
Omada Health, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.08
Actual
$0.01
Surprise
+112.22%
The Oncology Institute, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.02
Surprise
+74.46%
LifeMD, Inc. Common Stock
Report Date
May 06, 2026 For Q1 26
Estimate
-$0.22
Actual
-$0.20
Surprise
+12.85%
SkinHealth Systems Inc. Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.05
Surprise
+36.47%
Natera, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.54
Actual
-$0.56
Surprise
-2.36%
Viatris Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.51
Actual
$0.59
Surprise
+15.17%
Charles River Laboratories International, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$1.96
Actual
$2.06
Surprise
+4.98%
Caris Life Sciences, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.02
Actual
$0.00
Surprise
+100.00%
FAQ
What were GoodRx Holdings, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, GoodRx Holdings, Inc. Class A Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to GoodRx Holdings, Inc. Class A Common Stock's Q1 2026 earnings?
The stock price moved up 10.51%, changed from $2.57 before the earnings release to $2.84 the day after.
When is GoodRx Holdings, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for Aug 04, 2026.
What are the forecasts for GoodRx Holdings, Inc. Class A Common Stock's next earnings report?
Based on 12
analysts, GoodRx Holdings, Inc. Class A Common Stock is expected to report EPS of $0.08 and revenue of $193.84M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement